Nadia El Mouaddin

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Imperial Consultants

Nadia El Mouaddin is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in vaccination, preventive medicine, and vaccination policy.

ORCID

Publications per year

2020–2020

Publications

Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France

Laureen Majed, Xavier Bresse, Nadia El Mouaddin et al. · Vaccine · 2020 · 31 citations

Veterinary Medicine, Health Policy, Preventive Medicine +14

Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland

André B. Kind, Andrew Pavelyev, Smita Kothari et al. · BMC Public Health · 2020 · 14 citations · Full text

Medicine, Oncology, Preventive Medicine +17

1–2 of 2